Evidence map›Paper›PMID 38835667›Full record

ArticleFrontiers in pharmacology2024

MPASL: multi-perspective learning knowledge graph attention network for synthetic lethality prediction in human cancer.

Ge Zhang, Yitong Chen, Chaokun Yan, Jianlin Wang, Wenjuan Liang, Junwei Luo, Huimin Luo

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ge ZhangSchool of Computer and Information Engineering, Henan University, Kaifeng, Henan, China.
Yitong ChenSchool of Computer and Information Engineering, Henan University, Kaifeng, Henan, China.
Chaokun YanSchool of Computer and Information Engineering, Henan University, Kaifeng, Henan, China.
Jianlin WangSchool of Computer and Information Engineering, Henan University, Kaifeng, Henan, China.
Wenjuan LiangSchool of Computer and Information Engineering, Henan University, Kaifeng, Henan, China.
Junwei LuoCollege of Computer Science and Technology, Henan Polytechnic University, Jiaozuo, Henan, China.
Huimin LuoSchool of Computer and Information Engineering, Henan University, Kaifeng, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic lethality (SL) is widely used to discover the anti-cancer drug targets. However, the identification of SL interactions through wet experiments is costly and inefficient. Hence, the development of efficient and high-accuracy computational methods for SL interactions prediction is of great significance. In this study, we propose MPASL, a multi-perspective learning knowledge graph attention network to enhance synthetic lethality prediction. MPASL utilizes knowledge graph hierarchy propagation to explore multi-source neighbor nodes related to genes. The knowledge graph ripple propagation expands gene representations through existing gene SL preference sets. MPASL can learn the gene representations from both gene-entity perspective and entity-entity perspective. Specifically, based on the aggregation method, we learn to obtain gene-oriented entity embeddings. Then, the gene representations are refined by comparing the various layer-wise neighborhood features of entities using the discrepancy contrastive technique. Finally, the learned gene representation is applied in SL prediction. Experimental results demonstrated that MPASL outperforms several state-of-the-art methods. Additionally, case studies have validated the effectiveness of MPASL in identifying SL interactions between genes.

Indexed as

attention mechanismdeep learningknowledge graphmulti-perspective learningsynthetic lethality prediction

Identifiers

PMID38835667
PMCPMC11148462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.